HUMAGINE
DEAD

Serial Number

87023451

Owner

Celgene Corporation

Attorney

Camille M. Miller

Filing Date

May 3, 2016

Add to watchlist:

No watchlists yet
View on USPTO

HUMAGINE Trademark

Serial Number: 87023451 • Registration: 5253873

HUMAGINE is a trademark filed by Celgene Corporation on May 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Celgene Corporation (883 trademarks)

7 Powder Horn Drive
Warren, NJ 07059

Entity Type: 03

Trademark Details

Filing Date

May 3, 2016

Registration Date

August 1, 2017

Published for Opposition

May 16, 2017

Cancellation Date

February 16, 2024

Goods & Services

Providing educational and training services, namely, conducting classes, seminars and workshops in the field of cancer and associated dermatological and immune related disorders; educational services, namely, conducting live and online training in the field of treatment of cancer and associated dermatological and immune related disorders; education services, namely, providing on-line classes, seminars and workshops in the field of cancer and associated dermatological and immune related disorders; arranging and conducting of lectures in the field of cancer and associated dermatological and immune related disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line non-downloadable electronic publications, namely, books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials in the field of cancer and associated dermatological and immune related disorders; publication of electronic books, booklets, brochures, papers, periodical publications, magazines, newspapers and newsletters, leaflets, and instructional and teaching materials online in the field of cancer and associated dermatological, and immune related disorders; providing online educational games in the field of cancer and associated dermatological and immune related disorders and the treatment thereof

Pharmaceutical preparations for the treatment of cancer and associated dermatological and immune disorders

Business administration of patient reimbursement programs; business administration of pharmacy reimbursement programs and services

Personal and social services rendered by others to meet the needs of individuals, namely, providing non-therapeutic emotional counseling and emotional support to patients and families of patients, and providing information to relatives on how to provide emotional support to patients and families of patients

Providing medical information, consultancy and advisory services in the field of health; medical and pharmaceutical consultation; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical counseling; medical services, namely, medical care in the field of cancer and associated dermatological and immune related disorders; planning of medical treatment programs for the treatment of cancer and associated dermatological and immune related disorders; providing information and advice in the fields of cancer and associated dermatological and immune related disorders; providing a web site featuring medical information

Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and associated dermatological and immune related disorders; conducting clinical trials for pharmaceutical products in the field of cancer and associated dermatological and immune related disorders; providing information about the results of clinical trials for pharmaceutical products; providing online non-downloadable software applications containing information on the use of pharmaceutical products and for calculating use of medicine

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 16, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 1, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 1, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 11, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 6, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 27, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 27, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 27, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2016 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2016 TEME
ASSIGNED TO LIE
Nov 22, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2016 TROA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 2, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2016 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2016 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2016 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2016 NWOS
NEW APPLICATION ENTERED
May 6, 2016 NWAP